3-methylglutaconic acid has been researched along with Cochlear Hearing Loss in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duszynski, J; Jurkiewicz, E; Karkucinska-Wieckowska, A; Lebiedzinska, M; Pajdowska, M; Pinton, P; Pronicka, E; Pronicki, M; Suski, J; Szymanska-Debinska, T; Trubicka, J; Wieckowski, MR | 1 |
de Koning, T; Engelke, U; Huizing, M; Kluijtmans, LA; Loupatty, FJ; Morava, E; Rodenburg, RJ; Smeitink, JA; Wevers, R; Wortmann, S | 1 |
2 other study(ies) available for 3-methylglutaconic acid and Cochlear Hearing Loss
Article | Year |
---|---|
Increased reactive oxygen species (ROS) production and low catalase level in fibroblasts of a girl with MEGDEL association (Leigh syndrome, deafness, 3-methylglutaconic aciduria).
Topics: Catalase; Child, Preschool; Deafness; Female; Fibroblasts; Glutarates; Hearing Loss, Sensorineural; Humans; Leigh Disease; Mitochondrial Diseases; Reactive Oxygen Species | 2011 |
Association of 3-methylglutaconic aciduria with sensori-neural deafness, encephalopathy, and Leigh-like syndrome (MEGDEL association) in four patients with a disorder of the oxidative phosphorylation.
Topics: Adolescent; Brain Diseases, Metabolic; Child; Child, Preschool; Consanguinity; Fatal Outcome; Female; Glutarates; Hearing Loss, Sensorineural; Humans; Infant, Newborn; Leigh Disease; Male; Mitochondrial Diseases; Oxidative Phosphorylation; Syndrome; Valerates | 2006 |